We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

159 hedge funds and large institutions have $1.13B invested in Cardiovascular Systems, Inc. in 2018 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 46 increasing their positions, 52 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

169% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 13

23% more capital invested

Capital invested by funds: $914M → $1.13B (+$213M)

16% more funds holding

Funds holding: 137159 (+22)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

12% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 52

51% less call options, than puts

Call options by funds: $1.1M | Put options by funds: $2.24M

Holders
159
Holders Change
+22
Holders Change %
+16.06%
% of All Funds
3.64%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
35
Increased
46
Reduced
52
Closed
13
Calls
$1.1M
Puts
$2.24M
Net Calls
-$1.14M
Net Calls Change
-$1.28M
Name Holding Trade Value Shares
Change
Change in
Stake
CI
126
Cigna Investments
Connecticut
$236K +$311K +8,416 New
CCT
127
Country Club Trust
Missouri
$235K +$222K +6,000 New
II
128
Ibex Investors
Colorado
$219K +$207K +5,592 New
DWT
129
Dorsey & Whitney Trust
South Dakota
$210K +$198K +5,357 New
PP
130
Paloma Partners
Connecticut
$202K +$190K +5,147 New
Janus Henderson Group
131
Janus Henderson Group
United Kingdom
$202K +$191K +5,170 New
Legal & General Group
132
Legal & General Group
United Kingdom
$195K -$7.84K -212 -4%
NIT
133
NumerixS Investment Technologies
British Columbia, Canada
$165K +$155K +4,200 New
VCM
134
Versant Capital Management
Arizona
$147K +$139K +3,763 New
Citigroup
135
Citigroup
New York
$135K -$44.5K -1,205 -26%
Canada Life
136
Canada Life
Manitoba, Canada
$125K
WEC
137
Winslow Evans & Crocker
Massachusetts
$118K -$37K -1,000 -25%
Zurich Cantonal Bank
138
Zurich Cantonal Bank
Switzerland
$113K
AIP
139
Ameritas Investment Partners
Nebraska
$110K
HFM
140
Harvest Fund Management
China
$108K +$102K +2,749 New
BNP Paribas Financial Markets
141
BNP Paribas Financial Markets
France
$73K -$4.36K -118 -6%
TDC
142
Thompson Davis & Co
Virginia
$64K -$4.62K -125 -7%
PCM
143
Prelude Capital Management
New York
$43K -$58.7K -1,589 -59%
Group One Trading
144
Group One Trading
Illinois
$42K -$41.8K -1,132 -51%
PAM
145
Panagora Asset Management
Massachusetts
$39K
IA
146
IFP Advisors
Florida
$39K +$37K +1,000 New
QT
147
Quantbot Technologies
New York
$36K -$79.5K -2,151 -70%
TRCT
148
Tower Research Capital (TRC)
New York
$33K -$524K -14,171 -94%
AG
149
Advisor Group
Arizona
$23K +$22.2K +600 New
LTFS
150
Ladenburg Thalmann Financial Services
Florida
$23K +$22.2K +600 New

CSII Hedge Fund Activity: Q3 2018 in Review

159 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q3 2018, worth a combined $1.13B — up 23% from $914M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new CSII positions and 13 closed out — a net gain of 22 holders — while 46 added to existing stakes and 52 trimmed.

The largest buyer was Brown Capital Management, adding an estimated $22.3M. The largest seller was Camber Capital Management, exiting entirely with an estimated $53.3M sold.

  • 159 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q3 2018, up from 137 in Q2 2018.
  • Funds reported $1.13B of Cardiovascular Systems, Inc. stock for Q3 2018, up 23% quarter-over-quarter.
  • 35 funds opened new Cardiovascular Systems, Inc. positions in Q3 2018 and 13 closed out, a net change of +22 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q3 2018 was Brown Capital Management, an estimated $22.3M added.
  • The largest Cardiovascular Systems, Inc. seller in Q3 2018 was Camber Capital Management, an estimated $53.3M sold.

Based on aggregated 13F filings for Q3 2018.